US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 12.390
  • -0.590-4.55%
Close May 8 16:00 ET
745.66MMarket Cap-1476P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sage Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

Apr 25, 2024

Revenue(YoY)

7.90M

+139.89%
EPS(YoY)

-1.80

+26.83%
Analyst Rating

Hold

Apr 30, 2024

Sage Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 11.610M--
--2024/Q2-- / 9.225M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--
Nov 7, 20232023/Q32.716M / 3.173M--
Aug 7, 20232023/Q22.474M / 2.914M--
May 2, 20232023/Q13.294M / 2.283M--
Feb 16, 20232022/Q42.865M / 1.940M--
Nov 8, 20222022/Q31.739M / 1.659M--
Aug 2, 20222022/Q21.501M / 1.769M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 11.610M--
--2024/Q2-- / 9.225M--
Apr 25, 20242024/Q17.902M / 5.187M--
Feb 14, 20242023/Q477.972M / 60.976M--
Nov 7, 20232023/Q32.716M / 3.173M--
Aug 7, 20232023/Q22.474M / 2.914M--
May 2, 20232023/Q13.294M / 2.283M--
Feb 16, 20232022/Q42.865M / 1.940M--
Nov 8, 20222022/Q31.739M / 1.659M--
Aug 2, 20222022/Q21.501M / 1.769M--

Unlock Free Earnings Estimates

Sage Therapeutics Earnings Reports

  • Sage Therapeutics | 10-Q: Quarterly report

    Apr 25 19:20

  • Sage Therapeutics | 10-K: Annual report

    Feb 14 20:22

  • Sage Therapeutics: Q3 2023 Earnings Report

    Nov 7, 2023 20:00

  • Sage Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 7, 2023 19:20

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 30, 2024

    Hold

    • Buy

      16.67%

    • Hold

      77.78%

    • Sell

      5.56%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg